See more : Hillstream BioPharma, Inc. (HILS) Income Statement Analysis – Financial Results
Complete financial analysis of Soiken Holdings Inc. (2385.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Soiken Holdings Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Olympus Corporation (OCPNY) Income Statement Analysis – Financial Results
- Forum Mobile, Inc. (FRMB) Income Statement Analysis – Financial Results
- Regina Miracle International (Holdings) Limited (2199.HK) Income Statement Analysis – Financial Results
- FIH Mobile Limited (FXCNF) Income Statement Analysis – Financial Results
- Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ) Income Statement Analysis – Financial Results
Soiken Holdings Inc. (2385.T)
About Soiken Holdings Inc.
Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.16B | 8.08B | 9.35B | 8.94B | 9.31B | 7.57B | 5.46B | 4.15B | 3.21B | 2.55B | 2.34B | 1.97B | 1.55B | 1.52B | 1.44B | 1.98B | 2.55B |
| Cost of Revenue | 2.68B | 4.36B | 5.09B | 4.83B | 5.07B | 3.58B | 2.33B | 1.69B | 1.34B | 1.09B | 946.55M | 708.14M | 523.27M | 486.36M | 431.67M | 595.82M | 730.65M |
| Gross Profit | 2.48B | 3.72B | 4.26B | 4.11B | 4.25B | 3.98B | 3.12B | 2.46B | 1.87B | 1.46B | 1.40B | 1.26B | 1.03B | 1.03B | 1.01B | 1.38B | 1.82B |
| Gross Profit Ratio | 48.12% | 45.99% | 45.57% | 45.99% | 45.61% | 52.64% | 57.24% | 59.33% | 58.35% | 57.17% | 59.60% | 63.99% | 66.21% | 68.01% | 70.10% | 69.91% | 71.32% |
| Research & Development | 0.00 | 56.34M | 37.01M | 80.18M | 61.52M | 81.60M | 117.61M | 42.54M | 49.46M | 28.00M | 29.00M | 30.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.53B | 1.53B | 1.54B | 1.59B | 1.52B | 2.80B | 2.20B | 879.35M | 777.00M | 761.00M | 683.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 1.38B | 1.47B | 1.56B | 1.51B | 1.48B | 1.25B | 1.10B | 740.00M | 648.00M | 564.00M | 464.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.09B | 2.91B | 3.00B | 3.10B | 3.10B | 2.99B | 2.80B | 2.20B | 1.62B | 1.43B | 1.33B | 1.15B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 1.19M | 47.21M | 693.00K | 19.33M | 677.00K | 9.11M | 391.00K | 302.00K | 1.22M | 660.00K | 6.66M | 565.00K | 17.15M | 3.14M | 10.96M | 18.20M |
| Operating Expenses | 3.09B | 2.99B | 3.05B | 3.20B | 3.20B | 3.12B | 2.80B | 2.20B | 1.69B | 1.47B | 1.37B | 1.20B | 1.21B | 1.35B | 1.68B | 1.61B | 1.84B |
| Cost & Expenses | 5.77B | 7.35B | 8.14B | 8.03B | 8.26B | 6.70B | 5.13B | 3.88B | 3.03B | 2.56B | 2.32B | 1.91B | 1.74B | 1.84B | 2.11B | 2.20B | 2.57B |
| Interest Income | 59.00K | 337.00K | 153.00K | 159.00K | 3.39M | 6.26M | 7.01M | 6.83M | 8.53M | 15.65M | 8.53M | 9.85M | 4.28M | 3.84M | 6.92M | 28.21M | 44.00M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.00K | 0.00 | 0.00 | 0.00 | 0.00 | 60.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 26.80M | 24.78M | 23.85M | 31.34M | 35.14M | 34.49M | 31.59M | 20.92M | 15.59M | 16.08M | 18.15M | 18.17M | 20.97M | 22.04M | 569.21M | 101.73M | 133.89M |
| EBITDA | -583.21M | 750.07M | 1.28B | 948.13M | 1.08B | 901.32M | 363.95M | 292.66M | 187.07M | 6.00M | 45.94M | 110.86M | -166.94M | -297.17M | -97.75M | -193.31M | 113.18M |
| EBITDA Ratio | -11.31% | 9.31% | 13.20% | 10.73% | 11.31% | 11.95% | 6.83% | 7.06% | 6.79% | 0.30% | 1.96% | 2.88% | -11.05% | -20.43% | 26.56% | -9.76% | 9.55% |
| Operating Income | -610.01M | 725.71M | 1.21B | 916.79M | 1.05B | 866.83M | 325.56M | 264.43M | 182.65M | -9.56M | 27.79M | 57.39M | -187.92M | -319.21M | -666.95M | -223.46M | -20.71M |
| Operating Income Ratio | -11.83% | 8.98% | 12.93% | 10.25% | 11.25% | 11.45% | 5.97% | 6.38% | 5.68% | -0.38% | 1.19% | 2.92% | -12.14% | -21.00% | -46.19% | -11.28% | -0.81% |
| Total Other Income/Expenses | -4.66M | -426.00K | 43.77M | -8.36M | 42.58M | 7.79M | 6.72M | 7.31M | -11.17M | 15.73M | 9.16M | 35.30M | 8.95M | 34.30M | -471.22M | 110.75M | 14.38M |
| Income Before Tax | -614.67M | 725.29M | 1.25B | 908.43M | 1.09B | 874.62M | 332.28M | 271.73M | 171.48M | 6.16M | 36.95M | 92.69M | -178.97M | -284.91M | -1.14B | -112.71M | -6.33M |
| Income Before Tax Ratio | -11.92% | 8.98% | 13.40% | 10.16% | 11.71% | 11.56% | 6.09% | 6.55% | 5.34% | 0.24% | 1.58% | 4.71% | -11.56% | -18.74% | -78.83% | -5.69% | -0.25% |
| Income Tax Expense | 48.39M | 269.65M | 435.35M | 327.65M | 344.29M | 302.03M | 126.40M | 85.16M | 95.94M | 12.53M | 16.59M | 29.02M | 10.24M | 4.34M | 12.14M | 75.16M | 98.94M |
| Net Income | -662.20M | 451.85M | 809.71M | 562.06M | 731.69M | 553.47M | 197.98M | 186.57M | 46.71M | -5.52M | 26.03M | 69.55M | -184.14M | -284.99M | -1.15B | -163.08M | -95.93M |
| Net Income Ratio | -12.84% | 5.59% | 8.66% | 6.29% | 7.86% | 7.31% | 3.63% | 4.50% | 1.45% | -0.22% | 1.11% | 3.54% | -11.89% | -18.75% | -79.31% | -8.23% | -3.77% |
| EPS | -25.32 | 17.27 | 30.95 | 21.49 | 27.97 | 21.16 | 7.57 | 7.13 | 1.79 | -0.21 | 0.99 | 2.66 | -7.06 | -10.92 | -44.07 | -6.29 | -3.71 |
| EPS Diluted | -25.32 | 17.27 | 30.95 | 21.49 | 27.97 | 21.16 | 7.57 | 7.13 | 1.79 | -0.21 | 0.99 | 2.57 | -7.06 | -10.92 | -44.07 | -6.29 | -3.71 |
| Weighted Avg Shares Out | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.11M | 26.09M | 26.09M | 25.99M | 25.93M | 25.89M |
| Weighted Avg Shares Out (Dil) | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 26.16M | 27.06M | 26.09M | 26.09M | 25.99M | 25.93M | 25.89M |
Source: https://incomestatements.info
Category: Stock Reports